210 related articles for article (PubMed ID: 8571310)
1. Effect of fibrinogen substitution in afibrinogenemia on hemorheology and platelet function.
Reininger AJ; Reininger CB; Spannagl M; Mellinghoff A; Porr A; Heinzmann U; Wurzinger LJ
Thromb Haemost; 1995 Sep; 74(3):853-8. PubMed ID: 8571310
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen: requirement for platelet aggregation and adhesion.
Brinkhous KM; Mason RG
Acta Univ Carol Med Monogr; 1972; 53():9-16. PubMed ID: 4598522
[No Abstract] [Full Text] [Related]
4. Platelet function by afibrinogenemia.
Awaad S; Helmy O; Fahmy A; Naga MA; Hassanene A; Wahsh E
Gaz Egypt Paediatr Assoc; 1976; 24(3-4):185-92. PubMed ID: 1032139
[TBL] [Abstract][Full Text] [Related]
5. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
[TBL] [Abstract][Full Text] [Related]
6. [Effects of tetrandrine on platelet aggregation, platelet adhesion and coagulation].
Wu S; Zhao Z; Qi H
Zhongguo Zhong Yao Za Zhi; 1990 Apr; 15(4):233-5, 255-6. PubMed ID: 2206376
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
[TBL] [Abstract][Full Text] [Related]
8. Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions.
Remijn JA; Wu YP; Ijsseldijk MJ; Zwaginga JJ; Sixma JJ; de Groot PG
Thromb Haemost; 2001 Apr; 85(4):736-42. PubMed ID: 11341513
[TBL] [Abstract][Full Text] [Related]
9. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic effect of daphnetin in the rat].
Qu SY; Jiang XL; Zhao XH; Pan DB; Wang XR; Chen YL; Pan G; Wu YJ
Yao Xue Xue Bao; 1986 Jul; 21(7):498-501. PubMed ID: 3811938
[No Abstract] [Full Text] [Related]
11. Effect of purified Vipera palestinae hemorrhagin on blood coagulation and platelet function.
Grotto L; Jerushalmy Z; De Vries A
Thromb Diath Haemorrh; 1969 Dec; 22(3):482-95. PubMed ID: 5382286
[No Abstract] [Full Text] [Related]
12. Hemorheological background of acetylsalicylic acid resistance.
Feher G; Koltai K; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
[TBL] [Abstract][Full Text] [Related]
13. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
[TBL] [Abstract][Full Text] [Related]
14. Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.
Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
Blut; 1975 Feb; 30(2):87-100. PubMed ID: 1111662
[TBL] [Abstract][Full Text] [Related]
15. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
16. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
18. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
20. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
